These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 23993964)
1. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer. Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964 [TBL] [Abstract][Full Text] [Related]
2. A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes. Alghamdi F; Guo M; Abdulkhalek S; Crawford N; Amith SR; Szewczuk MR Cell Signal; 2014 Jun; 26(6):1355-68. PubMed ID: 24583283 [TBL] [Abstract][Full Text] [Related]
5. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Hurtado M; Lozano JJ; Castellanos E; López-Fernández LA; Harshman K; Martínez-A C; Ortiz AR; Thomson TM; Paciucci R Gut; 2007 Sep; 56(9):1266-74. PubMed ID: 17452424 [TBL] [Abstract][Full Text] [Related]
6. G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling. Abdulkhalek S; Guo M; Amith SR; Jayanth P; Szewczuk MR Cell Signal; 2012 Nov; 24(11):2035-42. PubMed ID: 22759791 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207 [TBL] [Abstract][Full Text] [Related]
8. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway. Tsai PC; Hsieh CY; Chiu CC; Wang CK; Chang LS; Lin SR Toxicon; 2012 Oct; 60(5):734-43. PubMed ID: 22683533 [TBL] [Abstract][Full Text] [Related]
9. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling. Jayanth P; Amith SR; Gee K; Szewczuk MR Cell Signal; 2010 Aug; 22(8):1193-205. PubMed ID: 20347965 [TBL] [Abstract][Full Text] [Related]
10. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling. Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9. Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245 [TBL] [Abstract][Full Text] [Related]
12. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells. Qorri B; Harless W; Szewczuk MR Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404 [TBL] [Abstract][Full Text] [Related]
13. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
14. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling. Haxho F; Haq S; Szewczuk MR Cell Signal; 2018 Mar; 43():71-84. PubMed ID: 29277445 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts. Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020 [TBL] [Abstract][Full Text] [Related]
16. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Ozaki N; Ohmuraya M; Hirota M; Ida S; Wang J; Takamori H; Higashiyama S; Baba H; Yamamura K Mol Cancer Res; 2009 Sep; 7(9):1572-81. PubMed ID: 19737965 [TBL] [Abstract][Full Text] [Related]
17. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
18. Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells. Amin DN; Bielenberg DR; Lifshits E; Heymach JV; Klagsbrun M Microvasc Res; 2008 May; 76(1):15-22. PubMed ID: 18440031 [TBL] [Abstract][Full Text] [Related]
19. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Amith SR; Jayanth P; Franchuk S; Finlay T; Seyrantepe V; Beyaert R; Pshezhetsky AV; Szewczuk MR Cell Signal; 2010 Feb; 22(2):314-24. PubMed ID: 19796680 [TBL] [Abstract][Full Text] [Related]
20. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chun J; Kim YS Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]